Stay updated on Pembrolizumab and Chemo in Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Chemo in Bladder Cancer Clinical Trial page.

Latest updates to the Pembrolizumab and Chemo in Bladder Cancer Clinical Trial page
- Check6 days agoChange DetectedThe page now shows 'No longer looking for participants' and adds new help sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'. It also updates the Interventions heading from 'Intervention / Treatment' to 'Intervention/Treatment' and notes a revision change from v3.5.5 to v3.6.0.SummaryDifference0.1%

- Check14 days agoChange DetectedThe page's revision label changed from v3.5.4 to v3.5.5, signaling a new update to the page's version history. This is a minor metadata update and does not alter study details or results.SummaryDifference0.0%

- Check21 days agoChange DetectedThe Ukraine site entries were standardized to Kharkiv Oblast and two Kharkiv locations (61037 and 61070) were added, replacing the previous Kharkivs’ka Oblast references. The site's recruitment status was updated from Active, not recruiting to Completed with corresponding date updates.SummaryDifference0.2%

- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page now displays revision v3.5.4 for the study protocol, updating from the previous v3.5.3. This indicates an updated protocol document within the study record.SummaryDifference0.0%

- Check57 days agoChange DetectedUpdated the site’s revision/version indicator from v3.5.2 to v3.5.3, reflecting a software or page-release change rather than a modification to the trial information.SummaryDifference0.0%

- Check64 days agoChange DetectedAdded Revision: v3.5.2; removed Revision: v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab and Chemo in Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Chemo in Bladder Cancer Clinical Trial page.